CAR T-cell therapy (new technology)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CAR T-cell therapy (new technology), covering 2026-04-16 to 2026-04-16. Get the full timeline:
Most recent: Clinical Trial Update: Treatment of Relapsed or Refractory B-cell Lymphoma With Chimeric Antigen Receptor (CAR) T-cell Therapy Produced by a New Technology [Phase 1, Phase 2]